<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513476448</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513476448</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Relationship between cerebral microbleeds and cognitive function in lacunar infarct</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Min</given-names></name>
<xref ref-type="fn" rid="fn1-0300060513476448">*</xref>
<xref ref-type="aff" rid="aff1-0300060513476448">1</xref>
<xref ref-type="aff" rid="aff2-0300060513476448">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Maogang</given-names></name>
<xref ref-type="fn" rid="fn1-0300060513476448">*</xref>
<xref ref-type="aff" rid="aff3-0300060513476448">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Qizhang</given-names></name>
<xref ref-type="fn" rid="fn1-0300060513476448">*</xref>
<xref ref-type="aff" rid="aff4-0300060513476448">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yun</surname><given-names>Wenwei</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513476448">1</xref>
<xref ref-type="corresp" rid="corresp1-0300060513476448"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname><given-names>Zhizhong</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513476448">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yin</surname><given-names>Qin</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513476448">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Huang</surname><given-names>Qinsong</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513476448">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhu</surname><given-names>Wusheng</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513476448">2</xref>
<xref ref-type="corresp" rid="corresp2-0300060513476448"/>
</contrib>
</contrib-group>
<aff id="aff1-0300060513476448"><label>1</label>Department of Neurology, The Second People's Hospital of Changzhou Affiliated to Nanjing Medical University, Changzhou, Jiangsu, China</aff>
<aff id="aff2-0300060513476448"><label>2</label>Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China</aff>
<aff id="aff3-0300060513476448"><label>3</label>Department of Neurology, Yancheng City No.1 People’s Hospital (the Fourth Affiliated Hospital of Nantong University), Jiangsu, China</aff>
<aff id="aff4-0300060513476448"><label>4</label>Department of Neurology, Affiliated Shenzhen Shajing Hospital of Guangzhou Medical University (Shajing People's Hospital), Guangdong, China</aff>
<author-notes>
<fn fn-type="equal" id="fn1-0300060513476448"><label>*</label><p>These authors contributed equally to this work.</p></fn>
<corresp id="corresp1-0300060513476448">Dr Wenwei Yun, Department of Neurology, The Second People's Hospital of Changzhou Affiliated to Nanjing Medical University, 29 Xinglong Lane, Changzhou, 213000, Jiangsu, China. Email: <email>ywwxjyww@yahoo.com.cn</email></corresp>
<corresp id="corresp2-0300060513476448">Dr Wusheng Zhu, Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, 305 East Zhongshan Road, Nanjing 210002, Jiangsu, China. Email: <email>zwsemail@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>2</issue>
<fpage>347</fpage>
<lpage>355</lpage>
<history>
<date date-type="received"><day>1</day><month>8</month><year>2012</year></date>
<date date-type="accepted"><day>18</day><month>8</month><year>2012</year></date>
</history>
<permissions>
    <copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
    <copyright-year>2013</copyright-year>
    <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="sec12-0300060513476448"><title>Objective</title>
<p>Little is known about the impact of cerebral microbleeds on cognitive function. This study investigated the distribution of cerebral microbleeds and their impact on cognitive function, in patients with lacunar infarct.</p>
</sec>
<sec id="sec13-0300060513476448"><title>Methods</title>
<p>Patients with lacunar infarct were enrolled prospectively. Cerebral microbleeds were classified as absent, mild, moderate or severe, based on magnetic resonance imaging findings. Cognitive function was measured using the Montreal Cognitive Assessment (MoCA) questionnaire, with a total score of &lt;26 indicating cognitive impairment.</p>
</sec>
<sec id="sec14-0300060513476448"><title>Results</title>
<p>Of the 85 patients included in the study, 35 (41.2%) had cerebral microbleeds. They were more frequently observed in mixed and deep brain regions, but rarely in the cerebral lobes. Multiple logistic regression analysis demonstrated that presence of cerebral microbleeds (odds ratio [OR] 5.320), duration of education (OR 0.938) and age (OR 1.464) were independent predictors of cognitive impairment. There was a significant correlation between cerebral microbleed severity and MoCA score.</p>
</sec>
<sec id="sec15-0300060513476448"><title>Conclusion</title>
<p>The number and location of cerebral microbleeds were both closely associated with cognitive impairment, in patients with lacunar infarct.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Cerebral microbleed</kwd>
<kwd>cognition</kwd>
<kwd>ischaemic stroke</kwd>
<kwd>lacunar infarct</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513476448" sec-type="intro"><title>Introduction</title>
<p>Interest in cerebral microbleeds has increased with the widespread clinical use of magnetic resonance imaging (MRI). Cerebral microbleeds appear as small, round hypointense lesions on gradient-echo (GE) T2*-weighted MRI sequences and are characterized histologically by the presence of haemosiderin deposits around small blood vessels with a diameter &lt;200 µm.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref></sup> In general, histopathological analysis of cerebral microbleeds reveals two types of vascular pathological change: hypertensive vasculopathy and cerebral amyloid angiopathy.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref><xref ref-type="bibr" rid="bibr1-0300060513476448"/>–<xref ref-type="bibr" rid="bibr3-0300060513476448">3</xref></sup> Cerebral microbleeds are often detected in patients with ischaemic stroke, Alzheimer’s disease or cerebral amyloid angiopathy, but are also found in healthy elderly individuals, although the prevalence and distribution differs among these groups.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref></sup> Research has also indicated that cerebral microbleeds are associated with an increased risk of stroke recurrence and haemorrhagic transformation after ischaemic stroke.<sup><xref ref-type="bibr" rid="bibr4-0300060513476448">4</xref>,<xref ref-type="bibr" rid="bibr5-0300060513476448">5</xref></sup></p>
<p>A relationship between cerebral microbleeds and cognition has been demonstrated in some patients with ischaemic stroke,<sup><xref ref-type="bibr" rid="bibr6-0300060513476448">6</xref></sup> vascular cognitive impairment<sup><xref ref-type="bibr" rid="bibr7-0300060513476448">7</xref></sup> or Alzheimer's disease,<sup><xref ref-type="bibr" rid="bibr8-0300060513476448">8</xref></sup> but the impact of such bleeds on cognitive function in other patient populations has not been extensively described. Cerebral microbleeds may be associated with endothelial dysfunction and blood–brain barrier damage, which play significant roles in lacunar infarct, and may be damaging to neurons and nerve fibre function.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref>,<xref ref-type="bibr" rid="bibr9-0300060513476448">9</xref>,<xref ref-type="bibr" rid="bibr10-0300060513476448">10</xref></sup></p>
<p>Few studies have examined the relationship between cerebral microbleeds and cognitive function in patients with lacunar infarct. Using MRI, the present study prospectively investigated the regional distribution of cerebral microbleeds in the brains of Chinese patients with lacunar infarct, and examined the relationship between such bleeds and cognitive function, using the Montreal Cognitive Assessment (MoCA) questionnaire in these individuals.</p>
</sec>
<sec id="sec2-0300060513476448" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513476448"><title>Study Population</title>
<p>Patients with ischaemic stroke associated with lacunar infarct, presenting at the Department of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China, between July 2010 and September 2011, were recruited to this study. All patients were registered in the Nanjing Stroke Registry Programme. Lacunar infarct was defined as a clinical lacunar syndrome with a compatible lesion on MRI and computed tomography (CT) scans. All patients had routine investigations for stroke, including head MRI and CT scanning, electrocardiogram, cardiac ultrasonic contrast and Duplex ultrasound. Patients were eligible for study inclusion if they were of Chinese ethnicity, were aged ≥18 years, and if they had well-documented (clinical presentation and CT or MRI scan of the brain) ﬁrst-ever acute ischaemic stroke within the previous 7 days. Exclusion criteria were: (i) carotid or vertebral artery stenosis of &gt;50%, regardless of subcortical infarction or cortical infarction of any size; (ii) potential cardiac sources of embolism defined as high or moderate risk, based on the Trial of Org 10172 in Acute Stroke Treatment classification;<sup><xref ref-type="bibr" rid="bibr11-0300060513476448">11</xref></sup> (iii) subcortical infarction &gt;15 mm in diameter or cortical infarction; (iv) inability to undergo cerebral MRI; (v) history of neurological disorder or brain injury.</p>
<p>The study protocol was approved by the Institutional Review Board of Jinling Hospital and written informed consent was provided by patients or their legally authorized representatives.</p>
</sec>
<sec id="sec4-0300060513476448"><title>Clinical Assessment</title>
<p>Demographic data and clinical histories of participating patients were collected from the Nanjing Stroke Registry Programme. Hypertension was defined as the combination of a self-reported high blood pressure and use of antihypertensive medications, or blood pressure ≥140/90 mmHg on three occasions. The presence of diabetes mellitus was defined as a fasting blood glucose level of ≥125 mg/dl or use of antidiabetic medication. Coronary artery disease was defined as a history of myocardial infarction, coronary artery bypass grafting, coronary angioplasty, stenting or angina pectoris. Hyperlipidaemia was defined as elevated fasting total cholesterol concentrations or use of statins prior to stroke.</p>
</sec>
<sec id="sec5-0300060513476448"><title>MRI</title>
<p>Magnetic resonance imaging was performed with patients in the supine position using a 3.0 T system (MAGNETOM® Trio; Siemens, Erlangen, Germany) with a 12-channel head coil. Susceptibility-weighted images (SWI) were acquired with a long time-to-echo (TE), fully flow-compensated three-dimensional GE sequence with the following parameters: repetition time/TE, 28/20 ms; flip angle, 15°; rectangular field of view, 7/8; matrix size, 448 × 168; slice thickness, 2 mm; integrated parallel imaging technique factor, 2; acquisition time, 5 min. Images were obtained in the axial plane parallel to the bicommissural line. SWI sequences were reconstructed with the minimum intensity projection (minIP) algorithm and multiplanar reformation techniques to obtain images of 3–10 mm thickness, with positions comparable to those of routine sequences. The minIP algorithm enabled enhanced detection of images of veins while minimizing the signal from cerebral tissues.</p>
<p>Cerebral microbleeds were deﬁned as homogeneous rounded areas of signal loss with a diameter &lt;10 mm on SWI sequences. Hypointense lesions within the subarachnoid space, or those probably associated with calciﬁcation of the globus pallidum, traumatic brain injury or vascular degeneration, were excluded. Cerebral microbleeds were classified as absent, mild (1–2 microbleeds), moderate (3–10 microbleeds) or severe (&gt;10 microbleeds),<sup><xref ref-type="bibr" rid="bibr12-0300060513476448">12</xref></sup> and location was described as lobar (cortex/subcortex) or nonlobar (basal ganglia, thalamus and infratentorial area).<sup><xref ref-type="bibr" rid="bibr13-0300060513476448">13</xref></sup> Leukoaraiosis on CT and MRI in all stroke patients was graded using the Fazekas scale, which has been correlated with pathological severity in a postmortem validation study,<sup><xref ref-type="bibr" rid="bibr14-0300060513476448">14</xref></sup> modified to separate degrees of confluent leukoaraiosis, as previously described:<sup><xref ref-type="bibr" rid="bibr15-0300060513476448">15</xref></sup> grade 0, no leukoaraiosis; grade 1, mild leukoaraiosis (&gt;5 white-matter hyperintensities); grade 2, moderate confluent leukoaraiosis; grade 3, severe confluent leukoaraiosis.</p>
<p>Magnetic resonance images were evaluated by two experienced neurologists, blinded to clinical information.</p>
</sec>
<sec id="sec6-0300060513476448"><title>MoCA questionnaire</title>
<p>A Chinese version of the MoCA questionnaire was used in this study (available at: <ext-link ext-link-type="uri" xlink:href="http://www.mocatest.org">http://www.mocatest.org</ext-link>). The MoCA questionnaire is a 30-point test covering seven cognitive domains: (i) visuospatial/executive; (ii) naming; (iii) memory; (iv) attention; (v) language; (vi) abstraction; (vii) orientation. Cognitive impairment is indicated by a total MoCA score of &lt;26. A bonus point is given to individuals with &lt;12 years’ education.<sup><xref ref-type="bibr" rid="bibr16-0300060513476448">16</xref></sup></p>
</sec>
<sec id="sec7-0300060513476448"><title>Statistical Analyses</title>
<p>All statistical analyses were performed using the SPSS® statistical package, version 11.0 (SPSS Inc., Chicago, IL, USA) for Windows®. The interobserver agreement was determined by κ statistics. Baseline characteristics and MRI findings were compared between patients with normal (≥26 points) or subnormal (&lt;26 points) total MoCA scores, using the χ<sup>2</sup>-test and Mann–Whitney <italic>U</italic>-test. In addition to age and sex, clinical variables with a <italic>P</italic>-value of &lt;0.10 in univariate logistic regression analysis were entered into a multiple logistic regression analysis, to determine the independent factors contributing to a low MoCA score. Comparisons of the total MoCA score and subscores between cerebral microbleed-positive and -negative patients were performed using the Student’s <italic>t-</italic>test. Spearman’s rank correlation coefficient test was used to evaluate the correlation between severity of cerebral microbleeds and MoCA score. A <italic>P</italic>-value &lt;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="sec8-0300060513476448" sec-type="results"><title>Results</title>
<p>A total of 85 patients (60 [70.6%] males) with lacunar infarcts were included in this study; patients had a mean age ± SD of 68.39 ± 11.37 years and a mean ± SD total MoCA score of 22.91 ± 2.94. Interobserver agreement on the presence of cerebral microbleeds was high (κ = 0.92). Cerebral microbleeds were detected in 35 (41.2%) patients, among whom 30 (85.7%) had multiple microbleeds (≥2 bleeds). In the 35 patients with cerebral microbleeds, these were classified as mild in five (14.3%), moderate in 17 (48.6%) and severe in 13 (37.1%). Microbleeds were observed more frequently in deep or mixed brain regions, and rarely in strictly lobar (cortex/subcortex) locations. The distribution was strictly lobar in four of the 35 patients (11.4%), nonlobar in 18/35 patients (51.4%; 12 patients with microbleeds in the basal ganglia and six patients with microbleeds in the infratentorial brain regions) and in mixed regions in 13/35 (37.1%) patients.</p>
<p>Subnormal total MoCA scores (&lt;26) were found in 56 (65.9%) patients. Differences in baseline characteristics and MRI findings between patients with subnormal and normal total MoCA scores are shown in <xref ref-type="table" rid="table1-0300060513476448">Table 1</xref>. Compared with patients with normal MoCA scores, those with subnormal scores were more likely to be ≥65 years of age (<italic>P</italic> = 0.022), have &lt;12 years’ education (<italic>P</italic> = 0.009) or be hypertensive (<italic>P</italic> = 0.013). There were no significant differences between the two groups in terms of sex, prevalence of diabetes mellitus, coronary heart disease or degree of leukoaraiosis. A significantly higher number of patients with subnormal MoCA scores had cerebral microbleeds, compared with those with normal MoCA scores (<italic>P</italic> &lt; 0.001).
<table-wrap id="table1-0300060513476448" position="float"><label>Table 1.</label><caption><p>Demographic, clinical and magnetic resonance imaging characteristics of Chinese patients with lacunar infarcts (<italic>n</italic> = 85), stratified according to normal (≥26) or subnormal (&lt;26) Montreal Cognitive Assessment (MoCA) score.</p></caption>
<graphic alternate-form-of="table1-0300060513476448" xlink:href="10.1177_0300060513476448-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Characteristic</th>
<th colspan="2">MoCA score<hr/></th>
<th rowspan="2">χ<sup>2</sup> or <italic>t</italic> statistic</th>
<th rowspan="2">Statistical significance<sup><xref ref-type="table-fn" rid="table-fn2-0300060513476448">a</xref></sup></th>
</tr>
<tr><th>Normal <italic>n</italic> = 29</th>
<th>Subnormal <italic>n</italic> = 56</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Aged ≥65</td>
<td>9 (31.0)</td>
<td>30 (53.6)</td>
<td>5.22</td>
<td><italic>P</italic> = 0.022</td>
</tr>
<tr>
<td>Male sex</td>
<td>22 (75.9)</td>
<td>38 (67.9)</td>
<td>0.59</td>
<td>NS</td>
</tr>
<tr>
<td>≥12 years’ education</td>
<td>23 (79.3)</td>
<td>28 (50.0)</td>
<td>6.84</td>
<td><italic>P</italic> = 0.009</td>
</tr>
<tr>
<td>Hypertension</td>
<td>18 (62.1)</td>
<td>48 (85.7)</td>
<td>6.155</td>
<td><italic>P</italic> = 0.013</td>
</tr>
<tr>
<td>Diabetes mellitus</td>
<td>4 (13.8)</td>
<td>8 (14.3)</td>
<td>0.004</td>
<td>NS</td>
</tr>
<tr>
<td>Coronary heart disease</td>
<td>4 (13.8)</td>
<td>15 (26.8)</td>
<td>1.858</td>
<td>NS</td>
</tr>
<tr>
<td>Leukoaraiosis<sup><xref ref-type="table-fn" rid="table-fn4-0300060513476448">c</xref></sup></td>
<td>2 (1–3)</td>
<td>2 (1–3)</td>
<td>−0.574</td>
<td>NS<sup><xref ref-type="table-fn" rid="table-fn3-0300060513476448">b</xref></sup></td>
</tr>
<tr>
<td>Presence of cerebral microbleeds</td>
<td>5 (17.2)</td>
<td>30 (53.6)</td>
<td>15.709</td>
<td><italic>P</italic> &lt; 0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513476448"><p>Data presented as <italic>n</italic> (%) of patients or median (interquartile range).</p></fn>
<fn id="table-fn2-0300060513476448"><label>a</label><p>χ<sup>2</sup>-test.</p></fn>
<fn id="table-fn3-0300060513476448"><label>b</label><p>Mann–Whitney <italic>U</italic>-test.</p></fn>
<fn id="table-fn4-0300060513476448"><label>c</label><p>Leukoaraiosis was determined according to the Fazekas scale and modified to separate degrees of confluent leukoaraiosis: grade 0, no leukoaraiosis; grade 1, mild leukoaraiosis (&gt;5 white-matter hyperintensities); grade 2, moderate confluent leukoaraiosis; grade 3, severe confluent leukoaraiosis.</p></fn>
<fn id="table-fn5-0300060513476448"><p>NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Multiple logistic regression analysis revealed that the presence of cerebral microbleeds (<italic>P</italic> = 0.038), &lt;12 years’ education (<italic>P</italic> = 0.002) and age (<italic>P</italic> = 0.023) remained significantly associated with subnormal MoCA scores (<xref ref-type="table" rid="table2-0300060513476448">Table 2</xref>). A significant correlation between microbleed severity and MoCA score was determined by Spearman’s correlation coefficient (<italic>r</italic> = −0.538, <italic>P</italic> &lt; 0.001).
<table-wrap id="table2-0300060513476448" position="float"><label>Table 2.</label><caption><p>Multiple logistic regression analysis to determine independent factors associated with subnormal Montreal Cognitive Assessment scores (&lt;26 points) in Chinese patients with lacunar infarct (<italic>n</italic> = 85; subnormal scores were obtained in 56 patients.</p></caption>
<graphic alternate-form-of="table2-0300060513476448" xlink:href="10.1177_0300060513476448-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th>OR</th>
<th>95% CI</th>
<th>Statistical significance</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Presence of cerebral microbleeds</td>
<td>5.320</td>
<td>1.390, 20.256</td>
<td><italic>P</italic> = 0.038</td>
</tr>
<tr>
<td>≥12 years’ education</td>
<td>0.938</td>
<td>0.887, 0.938</td>
<td><italic>P</italic> = 0.002</td>
</tr>
<tr>
<td>Aged ≥65 years</td>
<td>1.464</td>
<td>1.145, 1.871</td>
<td><italic>P</italic> = 0.023</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0300060513476448"><p>OR, odds ratio; CI, confidence interval.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>For further analysis, the total patient population was stratified according to the presence (positive group) or absence (negative group) of cerebral microbleeds. Total MoCA scores and the visuospatial/executive and attention subscores were significantly lower in the positive group compared with the negative group (<italic>P</italic> &lt; 0.001 for all comparisons, <xref ref-type="table" rid="table3-0300060513476448">Table 3</xref>). The presence of cerebral microbleeds in the basal ganglia or in lobar regions (cortex/subcortex) was associated with significant reductions in the total MoCA score and visuospatial/executive subscore (<italic>P</italic> &lt; 0.05, <xref ref-type="table" rid="table4-0300060513476448">Table 4</xref>). Patients with microbleeds in the basal ganglia also had significantly reduced attention subscores, compared with those without such microbleeds (<italic>P</italic> &lt; 0.05). A reduction in the orientation subscore was observed in patients positive for cerebral microbleeds in the thalamus, compared with those negative for such microbleeds (<italic>P</italic> &lt; 0.05). There were no significant differences in the MoCA scores between patients with or without cerebral microbleeds in the infratentorial areas.
<table-wrap id="table3-0300060513476448" position="float"><label>Table 3.</label><caption><p>Montreal Cognitive Assessment (MoCA) total score and subscores in Chinese patients with lacunar infarct (<italic>n</italic> = 85), stratified according to the presence (positive) or absence (negative) of cerebral microbleeds, as determined by magnetic resonance imagin.</p></caption>
<graphic alternate-form-of="table3-0300060513476448" xlink:href="10.1177_0300060513476448-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>MoCA scores</th>
<th>Positive group <italic>n</italic> = 35</th>
<th>Negative group <italic>n</italic> = 50</th>
<th><italic>t</italic> statistic</th>
<th>Statistical significance<sup><xref ref-type="table-fn" rid="table-fn8-0300060513476448">a</xref></sup></th>
</tr></thead>
<tbody align="left">
<tr>
<td>Total score</td>
<td>19.98 ± 3.30</td>
<td>23.49 ± 2.95</td>
<td>−4.63</td>
<td><italic>P</italic> &lt; 0.001</td>
</tr>
<tr>
<td>Subscores</td>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td> Visuospatial/executive</td>
<td>2.73 ± 0.94</td>
<td>3.58 ± 0.84</td>
<td>−3.92</td>
<td><italic>P</italic> &lt; 0.001</td>
</tr>
<tr>
<td> Naming</td>
<td>2.83 ± 0.46</td>
<td>2.98 ± 0.16</td>
<td>−1.61</td>
<td>NS</td>
</tr>
<tr>
<td> Memory</td>
<td>1.83 ± 0.95</td>
<td>2.30 ± 1.09</td>
<td>−1.87</td>
<td>NS</td>
</tr>
<tr>
<td> Attention</td>
<td>4.20 ± 1.35</td>
<td>5.40 ± 0.98</td>
<td>−4.12</td>
<td><italic>P</italic> &lt; 0.001</td>
</tr>
<tr>
<td> Language</td>
<td>1.43 ± 0.57</td>
<td>1.70 ± 0.69</td>
<td>−1.73</td>
<td>NS</td>
</tr>
<tr>
<td> Abstraction</td>
<td>1.83 ± 0.38</td>
<td>1.95 ± 0.22</td>
<td>−1.51</td>
<td>NS</td>
</tr>
<tr>
<td> Orientation</td>
<td>5.13 ± 1.11</td>
<td>5.58 ± 0.71</td>
<td>−1.91</td>
<td>NS</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0300060513476448"><p>Data presented as mean ± SD.</p></fn>
<fn id="table-fn8-0300060513476448"><label>a</label><p>Student’s <italic>t</italic>-test.</p></fn>
<fn id="table-fn9-0300060513476448"><p>NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap>
<table-wrap id="table4-0300060513476448" position="float"><label>Table 4.</label><caption><p>Relationship between location of cerebral microbleeds and Montreal Cognitive Assessment (MoCA) total and subscores in Chinese patients with lacunar infarct (<italic>n</italic> = 85), stratified according to the presence (positive group) or absence (negative group) of cerebral microbleeds, as determined by magnetic resonance imagin.</p></caption>
<graphic alternate-form-of="table4-0300060513476448" xlink:href="10.1177_0300060513476448-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="3">MoCA scores</th>
<th colspan="8">Location of cerebral microbleeds<hr/></th>
</tr>
<tr><th colspan="2">Basal ganglia<hr/></th>
<th colspan="2">Thalamus<hr/></th>
<th colspan="2">Infratentorial region<hr/></th>
<th colspan="2">Lobar (cortex/subcortex)<hr/></th>
</tr>
<tr><th>Positive <italic>n</italic> = 20</th>
<th>Negative <italic>n</italic> = 65</th>
<th>Positive <italic>n</italic> = 19</th>
<th>Negative <italic>n</italic> = 66</th>
<th>Positive <italic>n</italic> = 13</th>
<th>Negative <italic>n = </italic>72</th>
<th>Positive <italic>n</italic> = 26</th>
<th>Negative <italic>n</italic> = 59</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Total score</td>
<td>20.10 ± 3.55</td>
<td>22.74 ± 3.27<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
<td>20.20 ± 3.97</td>
<td>22.52 ± 3.25</td>
<td>21.00 ± 2.52</td>
<td>22.41 ± 3.56</td>
<td>20.32 ± 3.32</td>
<td>22.76 ± 3.40<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
</tr>
<tr>
<td>Subscores</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td> Visuospatial/executive</td>
<td>2.75 ± 0.97</td>
<td>3.40 ± 0.93<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
<td>2.88 ± 1.03</td>
<td>3.31 ± 0.95</td>
<td>2.97 ± 0.99</td>
<td>3.33 ± 0.94</td>
<td>2.77 ± 0.92</td>
<td>3.42 ± 0.94<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
</tr>
<tr>
<td> Naming</td>
<td>2.90 ± 0.31</td>
<td>2.92 ± 0.34</td>
<td>2.88 ± 0.34</td>
<td>2.93 ± 0.33</td>
<td>2.92 ± 0.29</td>
<td>2.92 ± 0.34</td>
<td>2.77 ± 0.53</td>
<td>2.98 ± 1.44</td>
</tr>
<tr>
<td> Memory</td>
<td>1.90 ± 1.07</td>
<td>2.18 ± 1.04</td>
<td>2.00 ± 1.16</td>
<td>2.13 ± 1.03</td>
<td>1.78 ± 0.67</td>
<td>2.21 ± 1.09</td>
<td>1.91 ± 1.07</td>
<td>2.19 ± 1.05</td>
</tr>
<tr>
<td> Attention</td>
<td>4.15 ± 1.33</td>
<td>5.14 ± 1.22<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
<td>4.25 ± 1.44</td>
<td>5.07 ± 1.20</td>
<td>4.70 ± 1.17</td>
<td>4.97 ± 1.31</td>
<td>4.32 ± 1.40</td>
<td>5.15 ± 1.17</td>
</tr>
<tr>
<td> Language</td>
<td>1.40 ± 0.50</td>
<td>1.66 ± 0.69</td>
<td>1.44 ± 0.51</td>
<td>1.63 ± 0.68</td>
<td>1.43 ± 0.50</td>
<td>1.64 ± 0.67</td>
<td>1.55 ± 0.51</td>
<td>1.60 ± 0.71</td>
</tr>
<tr>
<td> Abstraction</td>
<td>1.80 ± 0.41</td>
<td>1.94 ± 0.24</td>
<td>1.81 ± 0.40</td>
<td>1.93 ± 0.26</td>
<td>1.83 ± 0.39</td>
<td>1.91 ± 0.28</td>
<td>1.86 ± 0.35</td>
<td>1.92 ± 0.28</td>
</tr>
<tr>
<td> Orientation</td>
<td>5.20 ± 1.12</td>
<td>5.50 ± 0.81</td>
<td>4.94 ± 1.18</td>
<td>5.52 ± 0.80<sup><xref ref-type="table-fn" rid="table-fn11-0300060513476448">a</xref></sup></td>
<td>5.37 ± 1.20</td>
<td>5.43 ± 0.86</td>
<td>5.14 ± 1.17</td>
<td>5.50 ± 0.77</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-0300060513476448"><p>Data presented as mean ± SD.</p></fn>
<fn id="table-fn11-0300060513476448"><label>a</label><p><italic>P</italic> &lt; 0.05 for positive versus negative group comparisons; Student’s <italic>t-</italic>test.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec9-0300060513476448" sec-type="discussion"><title>Discussion</title>
<p>In the present study, cerebral microbleeds were frequently observed in patients with lacunar infarcts, with nearly half of all patients having such bleeds (41.2%). The microbleeds appeared mainly in deep or mixed brain regions, but rarely occurred in strictly lobar (cortex/subcortex) locations. In addition, cerebral microbleeds were more often classified as moderate or severe, compared with mild. It has been postulated that the aetiology of microbleeds differs according to their location in the brain, with lobar microbleeds being caused by cerebral amyloid angiopathy, and nonlobar microbleeds (occurring in deep, infratentorial or mixed regions) resulting from arteriosclerosis.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref>,<xref ref-type="bibr" rid="bibr2-0300060513476448">2</xref></sup> Cerebral microbleeds may be indicative of microangiopathy in the cerebrovascular systems of patients with lacunar infarct. In addition, the presence of microbleeds in deep or mixed lobar locations might also serve as a marker of severe cerebrovascular burden, or suggest the presence of hypertensive damage.<sup><xref ref-type="bibr" rid="bibr17-0300060513476448">17</xref></sup> Hypertension and ageing have been shown to be important risk factors in the development of small-vessel disease.<sup><xref ref-type="bibr" rid="bibr9-0300060513476448">9</xref>,<xref ref-type="bibr" rid="bibr10-0300060513476448">10</xref></sup></p>
<p>In the present study, a significant correlation was determined between cognitive dysfunction and the presence of cerebral microbleeds, in patients with lacunar infarcts. Traditionally, cerebral microbleeds have been considered to be clinically silent, but some studies have demonstrated that they are associated with clinical changes such as cognitive dysfunction,<sup><xref ref-type="bibr" rid="bibr6-0300060513476448">6</xref>,<xref ref-type="bibr" rid="bibr18-0300060513476448">18</xref></sup> depression<sup><xref ref-type="bibr" rid="bibr19-0300060513476448">19</xref></sup> or neurological deterioration, in patients with lacunar infarct.<sup><xref ref-type="bibr" rid="bibr20-0300060513476448">20</xref></sup> Consistent with data from the present study, other research also suggests that cerebral microbleeds have an important effect on cognitive function, in patients with Alzheimer's disease<sup><xref ref-type="bibr" rid="bibr21-0300060513476448">21</xref></sup> or ischaemic stroke.<sup><xref ref-type="bibr" rid="bibr22-0300060513476448">22</xref>,<xref ref-type="bibr" rid="bibr23-0300060513476448">23</xref></sup> There are two possible explanations for the association of microbleeds with cognitive performance in patients with lacunar infarct. First, microbleeds are associated with the progression of microangiopathies.<sup><xref ref-type="bibr" rid="bibr1-0300060513476448">1</xref></sup> Cerebral microbleeds in lacunar infarcts may reflect severe blood–brain barrier breakdown, which is important in blood extravasation. Blood breakdown products from microbleeds in the cerebrovascular system (including haemosiderin, iron and ferritin) may cause neuronal damage around the blood vessels and profound neuroinflammation, as demonstrated in a rat model.<sup><xref ref-type="bibr" rid="bibr24-0300060513476448">24</xref></sup> Secondly, it has been suggested that the presence of cerebral microbleeds may indicate more severe disruption of the neural network between cortical and subcortical structures;<sup><xref ref-type="bibr" rid="bibr6-0300060513476448">6</xref></sup> cerebral microbleeds could affect, for example, the frontal–subcortical circuits that have important visuospatial or executive functions. The frequent detection of cerebral microbleeds in multiple brain regions (including the cortex, basal ganglia and thalamus) in the present study may be consistent with this hypothesis.</p>
<p>Data from the present study indicate that that the distribution of cerebral microbleeds may be relevant in terms of the dysfunction of various cognitive domains; the presence of microbleeds in particular brain regions had detrimental effects on associated cognitive functions. For example, thalamic microbleeds were associated with a significant reduction in the MoCA orientation subscore, lobar (cortex/subcortex) microbleeds were associated with significantly reduced visuospatial/executive subscores, and basal ganglia microbleeds were associated with significantly reduced attention and visuospatial/executive subscores.</p>
<p>Older age, shorter duration of education and the severity of leukoaraiosis have all been shown to have important impact on cognitive function.<sup><xref ref-type="bibr" rid="bibr25-0300060513476448">25</xref>,<xref ref-type="bibr" rid="bibr26-0300060513476448">26</xref></sup> Similarly, the current study demonstrated that age and education were significantly associated with cognitive dysfunction, but no association between the severity of leukoaraiosis and cognitive dysfunction could be determined in univariate logistic regression analysis. This may be because the prevalence of leukoaraiosis was high in patients with lacunar infarcts in the present study, such that there was no significant difference between patients with normal or subnormal MoCA scores.</p>
<p>In conclusion, the present study demonstrated that cerebral microbleeds had signiﬁcant impact on cognitive dysfunction in Chinese patients with lacunar infarct, and that the severity of such microbleeds was significantly correlated with MoCA scores. Furthermore, the distribution of cerebral microbleeds was associated with the type of cognitive dysfunction experienced by the patient. This small study provides preliminary data to suggest that cerebral microbleeds are important factors in cognitive function, in patients with lacunar infarct. Further prospective studies with larger sample sizes are, however, required to confirm these initial findings.</p>
</sec>
</body>
<back>
<sec id="sec10-0300060513476448"><title>Declaration of Conflicting Interest</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<sec id="sec11-0300060513476448"><title>Funding</title>
<p>This study was supported by the Natural Science Foundation of China (NSFC grant no. 81171099 to W.Z.) and the Science and Technology Programme Project in the Bao’an District, Shenzhen, Guangdong, China (grant no. 2010618).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0300060513476448"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>SM</given-names></name><name><surname>Vernooij</surname><given-names>MW</given-names></name><name><surname>Cordonnier</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Cerebral microbleeds: a guide to detection and interpretation</article-title>. <source>Lancet Neurol</source> <year>2009</year>; <volume>8</volume>: <fpage>165</fpage>–<lpage>17</lpage>.</citation></ref>
<ref id="bibr2-0300060513476448"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>SM</given-names></name><name><surname>Nandigam</surname><given-names>RN</given-names></name><name><surname>Delgado</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Microbleeds versus macrobleeds: evidence for distinct entities</article-title>. <source>Stroke</source> <year>2009</year>; <volume>40</volume>: <fpage>2382</fpage>–<lpage>2386</lpage>.</citation></ref>
<ref id="bibr3-0300060513476448"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fazekas</surname><given-names>F</given-names></name><name><surname>Kleinert</surname><given-names>R</given-names></name><name><surname>Roob</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds</article-title>. <source>AJNR Am J Neuroradiol</source> <year>1999</year>; <volume>20</volume>: <fpage>637</fpage>–<lpage>642</lpage>.</citation></ref>
<ref id="bibr4-0300060513476448"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nighoghossian</surname><given-names>N</given-names></name><name><surname>Hermier</surname><given-names>M</given-names></name><name><surname>Adeleine</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study</article-title>. <source>Stroke</source> <year>2002</year>; <volume>33</volume>: <fpage>735</fpage>–<lpage>742</lpage>.</citation></ref>
<ref id="bibr5-0300060513476448"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imaizumi</surname><given-names>T</given-names></name><name><surname>Horita</surname><given-names>Y</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study</article-title>. <source>J Neurosurg</source> <year>2004</year>; <volume>101</volume>: <fpage>915</fpage>–<lpage>920</lpage>.</citation></ref>
<ref id="bibr6-0300060513476448"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werring</surname><given-names>DJ</given-names></name><name><surname>Frazer</surname><given-names>DW</given-names></name><name><surname>Coward</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI</article-title>. <source>Brain</source> <year>2004</year>; <volume>127</volume>: <fpage>2265</fpage>–<lpage>2275</lpage>.</citation></ref>
<ref id="bibr7-0300060513476448"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SW</given-names></name><name><surname>Hwa Lee</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>EJ</given-names></name><etal/></person-group>. <article-title>Clinical significance of microbleeds in subcortical vascular dementia</article-title>. <source>Stroke</source> <year>2007</year>; <volume>38</volume>: <fpage>1949</fpage>–<lpage>1951</lpage>.</citation></ref>
<ref id="bibr8-0300060513476448"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yakushiji</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>M</given-names></name><name><surname>Yakushiji</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Brain microbleeds and global cognitive function in adults without neurological disorder</article-title>. <source>Stroke</source> <year>2008</year>; <volume>39</volume>: <fpage>3323</fpage>–<lpage>3328</lpage>.</citation></ref>
<ref id="bibr9-0300060513476448"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantoni</surname><given-names>L</given-names></name></person-group>. <article-title>Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges</article-title>. <source>Lancet Neurol</source> <year>2010</year>; <volume>9</volume>: <fpage>689</fpage>–<lpage>701</lpage>.</citation></ref>
<ref id="bibr10-0300060513476448"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>CS</given-names></name><name><surname>Hakim</surname><given-names>AM</given-names></name></person-group>. <article-title>Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis</article-title>. <source>Stroke</source> <year>2009</year>; <volume>40</volume>: <fpage>e322</fpage>–<lpage>e330</lpage>.</citation></ref>
<ref id="bibr11-0300060513476448"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>H</given-names></name><name><surname>Bendixen</surname><given-names>BH</given-names></name><name><surname>Kappelle</surname><given-names>LJ</given-names></name><etal/></person-group>. <article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</article-title>. <source>Stroke</source> <year>1993</year>; <volume>24</volume>: <fpage>35</fpage>–<lpage>41</lpage>.</citation></ref>
<ref id="bibr12-0300060513476448"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Bae</surname><given-names>HJ</given-names></name><name><surname>Yoon</surname><given-names>BW</given-names></name><etal/></person-group>. <article-title>Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions</article-title>. <source>Stroke</source> <year>2002</year>; <volume>33</volume>: <fpage>2845</fpage>–<lpage>2849</lpage>.</citation></ref>
<ref id="bibr13-0300060513476448"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>Izumiyama</surname><given-names>M</given-names></name><name><surname>Izumiyama</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis</article-title>. <source>Stroke</source> <year>2002</year>; <volume>33</volume>: <fpage>1536</fpage>–<lpage>1540</lpage>.</citation></ref>
<ref id="bibr14-0300060513476448"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fazekas</surname><given-names>F</given-names></name><name><surname>Kleinert</surname><given-names>R</given-names></name><name><surname>Offenbacher</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Pathologic correlates of incidental MRI white matter signal hyperintensities</article-title>. <source>Neurology</source> <year>1993</year>; <volume>43</volume>: <fpage>1683</fpage>–<lpage>1689</lpage>.</citation></ref>
<ref id="bibr15-0300060513476448"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>A</given-names></name><name><surname>Hunt</surname><given-names>BJ</given-names></name><name><surname>O’Sullivan</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis</article-title>. <source>Brain</source> <year>2003</year>; <volume>126</volume>: <fpage>424</fpage>–<lpage>432</lpage>.</citation></ref>
<ref id="bibr16-0300060513476448"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nasreddine</surname><given-names>ZS</given-names></name><name><surname>Phillips</surname><given-names>NA</given-names></name><name><surname>Bédirian</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment</article-title>. <source>J Am Geriatr Soc</source> <year>2005</year>; <volume>53</volume>: <fpage>695</fpage>–<lpage>699</lpage>.</citation></ref>
<ref id="bibr17-0300060513476448"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vernooij</surname><given-names>MW</given-names></name><name><surname>van der Lugt</surname><given-names>A</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study</article-title>. <source>Neurology</source> <year>2008</year>; <volume>70</volume>: <fpage>1208</fpage>–<lpage>1214</lpage>.</citation></ref>
<ref id="bibr18-0300060513476448"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Werring</surname><given-names>DJ</given-names></name><name><surname>Gregoire</surname><given-names>SM</given-names></name><name><surname>Cipolotti</surname><given-names>L</given-names></name></person-group>. <article-title>Cerebral microbleeds and vascular cognitive impairment</article-title>. <source>J Neurol Sci</source> <year>2010</year>; <volume>299</volume>: <fpage>131</fpage>–<lpage>135</lpage>.</citation></ref>
<ref id="bibr19-0300060513476448"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Cerebral microbleeds and symptom severity of post-stroke depression: a magnetic resonance imaging study</article-title>. <source>J Affect Disord</source> <year>2011</year>; <volume>129</volume>: <fpage>354</fpage>–<lpage>358</lpage>.</citation></ref>
<ref id="bibr20-0300060513476448"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>CY</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><etal/></person-group>. <article-title>Microbleeds and free active MMP-9 are independent risk factors for neurological deterioration in acute lacunar stroke</article-title>. <source>Eur J Neurol</source> <year>2011</year>; <volume>18</volume>: <fpage>158</fpage>–<lpage>164</lpage>.</citation></ref>
<ref id="bibr21-0300060513476448"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goos</surname><given-names>JD</given-names></name><name><surname>Kester</surname><given-names>MI</given-names></name><name><surname>Barkhof</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition</article-title>. <source>Stroke</source> <year>2009</year>; <volume>40</volume>: <fpage>3455</fpage>–<lpage>3460</lpage>.</citation></ref>
<ref id="bibr22-0300060513476448"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>WK</given-names></name><name><surname>Chen</surname><given-names>YK</given-names></name><name><surname>Lu</surname><given-names>JY</given-names></name><etal/></person-group>. <article-title>Absence of cerebral microbleeds predicts reversion of vascular ‘cognitive impairment no dementia’ in stroke</article-title>. <source>Int J Stroke</source> <year>2011</year>; <volume>6</volume>: <fpage>498</fpage>–<lpage>505</lpage>.</citation></ref>
<ref id="bibr23-0300060513476448"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gregoire</surname><given-names>SM</given-names></name><name><surname>Smith</surname><given-names>K</given-names></name><name><surname>Jäger</surname><given-names>HR</given-names></name><etal/></person-group>. <article-title>Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients</article-title>. <source>Cerebrovasc Dis</source> <year>2012</year>; <volume>33</volume>: <fpage>430</fpage>–<lpage>435</lpage>.</citation></ref>
<ref id="bibr24-0300060513476448"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>GA</given-names></name><name><surname>Navratil</surname><given-names>M</given-names></name><name><surname>Barone</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Proteolytic cascade enzymes increase in focal cerebral ischemia in rat</article-title>. <source>J Cereb Blood Flow Metab</source> <year>1996</year>; <volume>16</volume>: <fpage>360</fpage>–<lpage>366</lpage>.</citation></ref>
<ref id="bibr25-0300060513476448"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>DA</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Education modifies the relation of AD pathology to level of cognitive function in older persons</article-title>. <source>Neurology</source> <year>2003</year>; <volume>60</volume>: <fpage>1909</fpage>–<lpage>1915</lpage>.</citation></ref>
<ref id="bibr26-0300060513476448"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Groot</surname><given-names>JC</given-names></name><name><surname>De Leeuw</surname><given-names>FE</given-names></name><name><surname>Oudkerk</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study</article-title>. <source>Ann Neurol</source> <year>2000</year>; <volume>47</volume>: <fpage>145</fpage>–<lpage>151</lpage>.</citation></ref>
</ref-list>
</back>
</article>